Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

about

Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

Item

http://www.wikidata.org/entity/Q41162205

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

@en

type

Item

label

Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

@en

prefLabel

Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

@en

P1476

Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report

@en

P2093

Cicinelli Ettore

http://www.w3.org/2001/XMLSchema#string

Claudio Furino

http://www.w3.org/2001/XMLSchema#string

Emma Bassi

http://www.w3.org/2001/XMLSchema#string

Gennaro Cormio

http://www.w3.org/2001/XMLSchema#string

Rosa Martino

http://www.w3.org/2001/XMLSchema#string

Vera Loizzi

http://www.w3.org/2001/XMLSchema#string

P2860

Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.

Risks and benefits of taxanes in breast and ovarian cancer.

The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication.

A case of paclitaxel-induced maculopathy treated with methazolamide.

Drug-induced ocular disorders.

Review of dose-intense platinum and/or paclitaxel containing chemotherapy in advanced and recurrent epithelial ovarian cancer.

Cystic maculopathy with normal capillary permeability secondary to docetaxel.

Optical coherence tomography findings in nicotinic acid maculopathy.

[Peripheral neuropathy induced by anticancer drugs].

Cystoid macular edema secondary to Paclitaxel (abraxane).

P304

285-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1296

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Alessio

P577

2017-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28781803

http://www.w3.org/2001/XMLSchema#string

P932

5532694

http://www.w3.org/2001/XMLSchema#string